All
1.
The current status and trend of clinical pharmacology in developing countries
Andrew Walubo BMC Pharmacology and Toxicology 2013, 14 :49 (28 September 2013)
Abstract | Provisional PDF
| PubMed
2.
Tissue concentration of paraquat on day 32 after intoxication and failed bridge to transplantation by extracorporeal membrane oxygenation therapy
Anna Bertram, Sascha Sebastian Haenel, Johannes Hadem, Marius M Hoeper, Jens Gottlieb, Gregor Warnecke, Stanislav Kaschinski, Carsten Hafer, W Nikolaus Kühn-Velten, Detlef Günther, Jan T Kielstein BMC Pharmacology and Toxicology 2013, 14 :45 (6 September 2013)
Abstract | Full text | PDF
| ePUB | PubMed
3.
Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers
Isis B Yera-Alos, Liuba Alonso-Carbonell, Carmen M Valenzuela-Silva, Angela D Tuero-Iglesias, Martha Moreira-Martínez, Ivonne Marrero-Rodríguez, Ernesto López-Mola, Pedro A López-Saura BMC Pharmacology and Toxicology 2013, 14 :44 (3 September 2013)
Abstract | Full text | PDF
| ePUB | PubMed
4.
Memory loss during lenalidomide treatment: a report on two cases
Adeline Rollin-Sillaire, Xavier Delbeuck, Marianne Pollet, Marie-Anne Mackowiak, Pierre Lenfant, Marie-Pierre Noel, Thierry Facon, Xavier Leleu, Florence Pasquier, Emilie Le Rhun BMC Pharmacology and Toxicology 2013, 14 :41 (12 August 2013)
Abstract | Full text | PDF
| ePUB | PubMed
5.
The association between prescription change frequency, chronic disease score and hospital admissions: a case control study
Carolien GM Sino, Rutger Stuffken, Eibert R Heerdink, Marieke J Schuurmans, Patrick C Souverein, Toine (A) CG Egberts BMC Pharmacology and Toxicology 2013, 14 :39 (1 August 2013)
Abstract | Full text | PDF
| ePUB | PubMed
6.
Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance
Elizabeth Brunner, Deborah M Falk, Meghan Jones, Debashish K Dey, Chetan Shatapathy BMC Pharmacology and Toxicology 2013, 14 :38 (1 August 2013)
Abstract | Full text | PDF
| ePUB | PubMed
7.
Effects of packaging and storage conditions on the quality of amoxicillin-clavulanic acid – an analysis of Cambodian samples
Mohiuddin Khan, Kirara Hatanaka, Tey Sovannarith, Nam Nivanna, Lidia Cecilia Cadena Casas, Naoko Yoshida, Hirohito Tsuboi, Tsuyoshi Tanimoto, Kazuko Kimura BMC Pharmacology and Toxicology 2013, 14 :33 (18 June 2013)
Abstract | Full text | PDF
| ePUB | PubMed
8.
Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011
Lise Aagaard, Ebba Hansen BMC Pharmacology and Toxicology 2013, 14 :30 (13 June 2013)
Abstract | Full text | PDF
| ePUB | PubMed
9.
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus
Anita Kapur, Robin O’Connor-Semmes, Elizabeth K Hussey, Robert L Dobbins, Wenli Tao, Marcus Hompesch, Glenn A Smith, Joseph W Polli, Charles D James Jr, Imao Mikoshiba, Derek J Nunez BMC Pharmacology and Toxicology 2013, 14 :26 (13 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
10.
Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature
Maria AP Martins, Adriano MM Reis, Mariana F Sales, Vandack Nobre, Daniel D Ribeiro, Manoel OC Rocha, Antônio LP Ribeiro BMC Pharmacology and Toxicology 2013, 14 :27 (4 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
